Aldostérone Muscle Antisynthetase AAV vector Anti-Mi2 Anti‐mitochondrial antibodies Cardio-oncology Cytokines Myositis Anticorps anti-agalsidase Animals Female Antibodies AAV humoral immunity B cell homeostasis Humans Agalsidase Auto-immunité Acid-alpha-glucosidase Antibody responses COVID-19 Data integration Skeletal muscle Antisynthetase syndrome Inborn errors of metabolism Male Prognosis Analyses multidimensionnelles Lysosomal storage diseases Biomarker Systems biology Adverse drug reactions Interstitial lung disease Sphingosine-1-phosphate AAV AAV antibody Autoantibodies Myocarditis Middle Aged Abnormal movement Machine learning Anti-MDA5 autoantibodies Myositis and muscle disease Adeno-associated virus vector Dependovirus/genetics/immunology Dermatomyositis Cancer Auto-antibodies AAV vectors Anti-synthetase syndrome Pharmacology Anti-interleukin-6 Mass cytometry Autoantibody Immunotherapy Autoimmune diseases Arthritis Aldosterone Adjudication Adeno-associated virus Anémie hémolytique Adult Outcome measures Auto‐antibodies Biomarkers Idiopathic inflammatory myopathies DM Amyotrophic lateral sclerosis Bioelectrical impedance analysis Inflammatory myopathy Interferon Myopathy Aged Anti-drug antibodies Biopsy B-lymphocyte Biomarqueurs Gene therapy Adeno-associated vector IMNM Antisynthétase Acute Kidney Injury/epidemiology/etiology Immune checkpoint inhibitors Multidisciplinarity Assisted communication devices Inclusion body myositis Fabry disease Case reports Adolescence Anticorps spécifique des myosites Active Autoimmunity Amyotrophy IBM Anti-IgE IgG Antiphospholipid syndrome Anti-agalsidase antibodies Polymyositis Deep immune profiling Inflammation